Global Diagnostics Labs Market Outlook, 2029
The Global Diagnostic labs Market is segmented into By Testing Services (General and Clinical Testing, Physiological Function Testing (ECG, Echo, X-ray, Endoscopy, CT, MRI, and Others), Esoteric Testing, Specialized Testing, Non-invasive Prenatal Testing, Others), By Lab Type (Hospital-Based Labs, Single/Independent Laboratories, Physician Office Labs, Others), By Revenue Source (Healthcare Plan Operators and Insurers, Out-of-Pocket, Public System, Speciality Store , Online Retail).
- Bonafide Research
- 31-01-2024
- Pages : 163
- Figures : 38
- Tables : 84
- Region : Global
- Category : Lifescience
- Healthcare
The Global Dignostic Labs market is anticipated to cross USD 520 Billion by 2029 due to Increasing prevalence of chronic diseases
- Historical Period2018-2022
- Base Year2023
- Forecast Period2024-2029
- Market Size (2023) USD 333.58 Billion
- Market Size (2029) USD 520 Billion
- CAGR (2024-2029) 7.9%
- Largest Market North America
- Fastest Market Asia-Pacific
- Format
Featured Companies
- 1. Abbott Laboratories
- 2. Apollo Hospitals Enterprise Limited
- 3. IDEXX Laboratories, Inc.
- 4. F. Hoffmann-La Roche AG,
- 5. Laboratory Corporation
- 6. Siemens Healthineers
- 7. Quest Diagnostics
- 8. Thermo Fisher Scientific Inc
- 9. Eurofins Scientific SE
- More...
Diagnostic labs Market Market Analysis
Diagnostic labs are at the forefront of identifying diseases and medical conditions. Through various tests and examinations, they assist healthcare professionals in pinpointing the root cause of symptoms, facilitating accurate and timely diagnoses. From routine blood tests to advanced imaging techniques, diagnostic labs offer a wide array of services to aid in disease detection. Diagnostic labs play a pivotal role in the healthcare ecosystem by providing essential information for disease detection, monitoring, and treatment. These labs are instrumental in unraveling the mysteries of health conditions, enabling healthcare professionals to make informed decisions. Beyond diagnosing existing conditions, diagnostic labs play a crucial role in preventive healthcare. Regular screenings and tests allow for the early detection of potential health risks, enabling individuals to take proactive measures to prevent the onset or progression of diseases. This emphasis on preventive healthcare is a cornerstone in the shift towards more personalized and patient-centric approaches. For individuals managing chronic conditions, diagnostic labs provide a means of monitoring disease progression and evaluating the effectiveness of treatments. Regular monitoring through lab tests helps healthcare professionals adjust treatment plans as needed, ensuring optimal outcomes for patients. The rising demand for personalized healthcare presents significant opportunities for diagnostic labs. Advances in molecular diagnostics and genomics enable a more tailored approach to treatment, taking into account individual genetic profiles and variations. Emerging economies present untapped potential for the diagnostic labs market. As healthcare infrastructure improves and awareness of preventive healthcare grows, these regions offer new avenues for market expansion. Collaborations between diagnostic labs, healthcare providers, and technology companies present opportunities for innovation and improved service delivery. Strategic partnerships can enhance research and development efforts, accelerate the adoption of new technologies, and expand market reach. Automation has significantly improved the efficiency of diagnostic labs. Automated analyzers and robotic systems handle routine tasks, reducing human error and increasing the speed and accuracy of test results. Accreditation bodies such as the College of American Pathologists (CAP) and the Clinical Laboratory Improvement Amendments (CLIA) in the United States ensure that diagnostic labs adhere to rigorous quality and safety standards. According to the research report, “Global Diagnostic Labs Market Outlook, 2029” published by Bonafide Research, the market is anticipated to cross USD 520 Billion by 2029, increasing from USD 333.58 Billion in 2023. The market is expected to grow with 7.90% CAGR by 2024-29. The increasing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and cancer, has fueled the demand for diagnostic testing. Diagnostic labs play a crucial role in the early detection, monitoring, and management of these conditions, contributing to better patient outcomes. The global aging population is a major demographic trend contributing to the growth of diagnostic labs. Older individuals often require more frequent and comprehensive diagnostic testing for age-related health issues, creating a sustained demand for lab services. Global health challenges, including pandemics such as the COVID-19 crisis, highlight the critical role of diagnostic labs in disease detection and management. The need for rapid and widespread testing to control infectious diseases has led to increased investments and focus on diagnostic capabilities. The rise of patient empowerment and awareness has contributed to increased demand for diagnostic testing. Patients are more proactive in managing their health, seeking diagnostic information to understand their risk factors, make informed decisions, and actively participate in their healthcare journey. The regulatory landscape has adapted to accommodate technological advancements and ensure the quality and safety of diagnostic tests. Regulatory frameworks that facilitate innovation while maintaining rigorous standards have encouraged growth in the diagnostic labs market. Improved global connectivity and collaboration have facilitated the sharing of knowledge, expertise, and best practices among diagnostic labs worldwide. This interconnectedness has accelerated the adoption of new technologies and diagnostic approaches. In addition to that, the adoption of point-of-care testing, which provides immediate results at the location of patient care, has grown. This approach is particularly valuable in emergency situations and remote settings, contributing to the accessibility and convenience of diagnostic services.
Click Here to Download this information in a PDF
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleMarket Dynamic
Market Drivers • Technological Advancements: Technological advancements in diagnostic tools and techniques have significantly enhanced the precision, speed, and scope of diagnostic testing. Innovations such as molecular diagnostics, next-generation sequencing, and advanced imaging modalities contribute to more accurate and efficient disease detection. Improved technology allows diagnostic labs to offer a broader range of tests, including genetic and molecular profiling, leading to more personalized medicine. Faster and more accurate diagnostics support timely treatment decisions, contributing to better patient outcomes. • Increasing Prevalence of Chronic Diseases: The global rise in chronic diseases, such as diabetes, cardiovascular diseases, and cancer, is a key driver for the diagnostic labs market. Chronic conditions often require frequent monitoring, leading to a sustained demand for diagnostic testing. Diagnostic labs play a crucial role in the early detection, monitoring, and management of chronic diseases. The increasing burden of these conditions worldwide amplifies the need for diagnostic services, driving market growth. Market Challenges • Regulatory Compliance and Quality Assurance: Diagnostic labs operate in a highly regulated environment to ensure the accuracy and reliability of test results. Keeping up with evolving regulatory standards, obtaining certifications, and ensuring quality control pose challenges for diagnostic labs. Compliance with regulations is crucial to maintaining the integrity of diagnostic results and ensuring patient safety. Navigating the complexities of regulatory requirements requires significant resources and ongoing commitment from diagnostic labs. • Data Management and Integration: The increasing volume of diagnostic data generated by labs poses challenges related to efficient storage, management, and integration with electronic health records (EHRs). Ensuring data security and privacy is a growing concern. Effective data management is essential for providing comprehensive patient care. Integration with EHRs enables seamless communication between healthcare providers and diagnostic labs, but challenges related to interoperability and data security must be addressed. Market Trends • Rise of Personalized Medicine: Personalized medicine, which tailors medical treatment to individual characteristics, is a growing trend in the diagnostic labs market. Advances in genomics and molecular diagnostics enable more precise and individualized approaches to patient care. The trend towards personalized medicine influences diagnostic testing by focusing on identifying genetic markers, enabling targeted therapies, and optimizing treatment plans based on individual patient profiles. • Integration of Artificial Intelligence (AI) : The integration of artificial intelligence (AI) in diagnostic processes is a significant trend. Machine learning algorithms can analyze large datasets, identify patterns, and assist in interpreting complex diagnostic results, improving efficiency and accuracy. AI enhances the capabilities of diagnostic labs by automating tasks, reducing errors, and providing insights that may be challenging for humans to discern. This trend contributes to more efficient and data-driven decision-making in diagnostic processes. Covid-19 Impacts The surge in infections prompted an unprecedented demand for diagnostic testing, placing diagnostic labs at the forefront of the pandemic response. The need for rapid and widespread testing for SARS-CoV-2, the virus causing COVID-19, led to an acceleration of testing capabilities and the development of innovative diagnostic methods. Diagnostic labs worldwide faced immense challenges, including scaling up testing capacity, procuring necessary testing supplies, and adapting to evolving testing guidelines. The pandemic also accelerated the integration of technology, such as real-time polymerase chain reaction (RT-PCR) and rapid antigen tests, to meet the urgent demand for timely and accurate results. Furthermore, the experience gained from the pandemic response has paved the way for increased collaboration between diagnostic labs, healthcare providers, and governments, fostering a more agile and interconnected global diagnostic infrastructure. While the immediate focus has been on COVID-19 testing, the pandemic has underscored the importance of diagnostic labs in public health and has catalyzed advancements that may have lasting implications for the industry.
Diagnostic labs Market Segmentation
| By Testing Services | General and Clinical Testing | |
| Physiological Function Testing (ECG, Echo, X-ray, Endoscopy, CT, MRI, and Others) | ||
| Esoteric Testing | ||
| Specialized Testing | ||
| Non-invasive Prenatal Testing | ||
| Others | ||
| By Lab Type | Single/Independent Laboratories | |
| Physician Office Labs | ||
| Others | ||
| By Revenue Source | Healthcare Plan Operators and Insurers | |
| Out-of-Pocket | ||
| Public System | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Russia | ||
| Asia-Pacific | China | |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| South America | Brazil | |
| Argentina | ||
| Colombia | ||
| MEA | United Arab Emirates | |
| Saudi Arabia | ||
| South Africa | ||
Based on the testing services, general and clinical testing, encompassing a range of diagnostic procedures such as blood tests (hematology, clinical chemistry, immunology, microbiology, molecular diagnostics), urinalysis, urine culture, urine cytology, as well as stool and sputum tests, are leading in the global diagnostic labs market. General and clinical testing covers a wide spectrum of diagnostic applications, from routine health check-ups to the diagnosis and monitoring of various medical conditions. Blood tests, for example, can provide insights into hematological disorders, assess organ function, and detect infectious diseases. Blood tests, urinalysis, and stool tests are integral components of routine health check-ups, enabling healthcare professionals to assess overall health, detect early signs of diseases, and monitor chronic conditions. These tests offer a comprehensive overview of an individual's health status, facilitating preventive measures and timely interventions. Blood tests, including hematology and clinical chemistry panels, provide a baseline for diagnosing various medical conditions such as anemia, diabetes, and liver disorders. They are also crucial for monitoring treatment effectiveness and disease progression, aiding healthcare providers in adjusting treatment plans accordingly. Microbiology and molecular diagnostics play a crucial role in identifying infectious diseases. Diagnostic labs utilize these tests for detecting bacteria, viruses, and other pathogens in blood, urine, stool, and sputum samples. During outbreaks, such as the COVID-19 pandemic, molecular diagnostics became especially vital for rapid and accurate virus detection. Urine cytology, blood tests, and molecular diagnostics contribute to cancer screening and detection. These tests help identify specific markers associated with various cancers, aiding in the early diagnosis and treatment of malignancies. Molecular diagnostics, including genetic testing, enable the identification of specific genetic markers and mutations associated with certain diseases. This information guides healthcare professionals in developing patient-specific treatment plans, contributing to the paradigm of personalized medicine. Ongoing technological advancements, particularly in molecular diagnostics, have expanded the capabilities of these tests. Improved sensitivity and specificity, faster turnaround times, and the development of multiplex assays contribute to the attractiveness of these diagnostic methods in clinical settings. Hospital-based labs offer a comprehensive range of diagnostic services under one roof. This includes routine blood tests, pathology services, microbiology, molecular diagnostics, imaging services, and more. The ability to provide a wide array of tests makes hospital labs a one-stop solution for various diagnostic needs. Hospital-based labs are seamlessly integrated with inpatient and outpatient care facilities. This integration allows for faster turnaround times in obtaining test results and enables healthcare providers to make timely and informed decisions about patient care, especially in emergency situations. Hospital labs often collaborate closely with clinical departments and specialists within the hospital. This collaboration facilitates better communication between lab professionals and healthcare providers, ensuring a more holistic approach to patient diagnosis and treatment. Hospital-based labs are equipped to handle emergency situations and critical care scenarios. The ability to perform urgent diagnostic tests quickly, such as blood gas analysis or cardiac biomarker testing, is crucial in emergency departments and intensive care units, contributing to improved patient outcomes. Hospitals invest in advanced diagnostic technologies and equipment, allowing their labs to offer a wide range of sophisticated tests. Molecular diagnostics, genetic testing, and specialized imaging modalities are often available in hospital labs, providing more in-depth insights into complex medical conditions. Hospital labs typically have access to a team of skilled professionals, including pathologists, medical technologists, and specialized technicians. This in-house expertise ensures the accuracy and reliability of test results, fostering confidence among healthcare providers and patients. Hospital-based labs contribute to clinical decision support by providing detailed and relevant diagnostic information. This support aids healthcare professionals in developing appropriate treatment plans and interventions based on the patient's specific medical condition. Hospitals often have dedicated infrastructure and resources to conduct specialized testing, such as histopathology, cytogenetics, and advanced imaging studies. This capability enables hospitals to offer a comprehensive suite of diagnostic services, catering to a diverse range of medical needs. Insurers are increasingly focused on population health management, aiming to improve the overall health of their covered populations. Diagnostic labs play a pivotal role in this strategy by providing insights into prevalent health conditions and facilitating targeted interventions. As healthcare coverage expands globally, more individuals gain access to diagnostic services through insurance plans. The increased coverage translates to a larger pool of individuals who can seek diagnostic tests, contributing to the overall growth of the diagnostic labs market. Healthcare plans and insurers often encourage preventive care and health screenings as part of their coverage. This emphasis on early detection and preventive measures leads to an increased demand for diagnostic tests, benefiting diagnostic labs. Individuals with health insurance coverage are more likely to utilize healthcare services, including diagnostic tests, due to the financial support provided by insurance plans. This increased healthcare utilization contributes to the growth in demand for diagnostic services. Healthcare plan operators and insurers negotiate reimbursement rates with diagnostic labs, influencing the financial landscape for diagnostic services. Favorable reimbursement rates can incentivize labs to participate in insurance networks, expanding access for covered individuals. The shift towards value-based care models emphasizes the importance of preventive services and early intervention. Diagnostic labs play a crucial role in supporting these models by providing diagnostic information that contributes to improved patient outcomes. Insurers may incentivize the use of diagnostic services that align with value-based care objectives. While healthcare plan operators and insurers do not directly contribute to the revenue of diagnostic labs, their role in facilitating access to diagnostic services through coverage and reimbursement agreements can impact the utilization and growth of the diagnostic labs market. The collaborative relationship between diagnostic labs and healthcare payers is integral to the overall healthcare ecosystem, contributing to improved patient care and health outcomes.
Click Here to Download this information in a PDF
Diagnostic labs Market Market Regional Insights
North America's leadership in the global diagnostic labs market can be attributed to the region's prominence in the healthcare and life sciences sectors. North America, particularly the United States and Canada, boasts a well-developed and advanced healthcare infrastructure. The region has a high concentration of modern hospitals, clinics, and diagnostic facilities, providing a robust foundation for diagnostic lab services. North America is at the forefront of adopting and developing advanced diagnostic technologies. Diagnostic labs in the region often have access to state-of-the-art equipment, molecular diagnostics, next-generation sequencing, and other cutting-edge technologies, allowing for a comprehensive range of diagnostic tests. The region invests significantly in research and development activities related to healthcare and diagnostics. Academic institutions, research centers, and private entities collaborate to advance diagnostic capabilities, contributing to innovation and the introduction of new diagnostic tests. The prevalence of health insurance coverage in North America ensures that a substantial portion of the population has access to diagnostic services. Health insurance companies play a crucial role in facilitating the reimbursement of diagnostic tests, fostering a favorable environment for diagnostic labs. There is a growing emphasis on preventive healthcare in North America, encouraging regular health check-ups and screenings. This proactive approach to healthcare leads to increased demand for diagnostic tests, supporting the growth of diagnostic labs. The region faces a high prevalence of chronic diseases such as diabetes, cardiovascular conditions, and cancer. The need for ongoing monitoring and early detection of these diseases drives the demand for diagnostic services, positioning diagnostic labs as essential healthcare entities. Governments in North America allocate significant resources to healthcare and medical research. North America has well-established regulatory bodies, such as the Food and Drug Administration (FDA) in the United States and Health Canada, which oversee and regulate diagnostic tests. A robust regulatory framework ensures the quality, safety, and efficacy of diagnostic services, instilling confidence in healthcare providers and patients. The aging population in North America contributes to a higher demand for diagnostic services, as older individuals often require more extensive testing for age-related health conditions. This demographic trend supports the growth of diagnostic labs. North America, particularly the United States, is a global leader in biotechnology and pharmaceuticals. The presence of major biotech and pharmaceutical companies fosters collaborations with diagnostic labs, leading to advancements in diagnostic technologies and methodologies.
Click Here to Download this information in a PDF
Key Development
• In December 2022, Lupin Diagnostics has launched new regional reference laboratory in Indore. Newly launched regional lab is equipped with qualified clinical experts & automated, streamlined processes. This expansion will improve access to reliable, high quality, advanced testing centers & home care collection facilities at affordable prices. Newly launched lab will offer cytogenetics, molecular diagnostics, microbiology, cytology, hematology, flow cytometry, immunology, serology, biochemistry, etc. • In July 2022, Orange Health Diagnostic Lab is launched in New Delhi. Orange Health Diagnostic Lab is NABL accredited labs. With this launch of new lab, customers across the NCR region which includes, Noida, Gurgaon, Delhi, and Ghaziabad will able to avail wide range of diagnostic services in 60 minutes from comfort of their homes, and report will be available in six hours. New lab will offer molecular biology, serology, Covid RT-PCR testing, flow cytometry and hematology services. • In May 2022, Neuberg Diagnostic has launched new lab in Gurugram with 10 express diagnostic labs and 100 touchpoints across Haryana. New lab will offer wide variety of test and will able to process about 1000 samples per day and also provides results within given turnaround time. • In May 2022, PAMM Foundation has outsourced its laboratory activities for pathology and medical microbiology to Eurofins Clinical Diagnostics Netherlands. Eurofins has announced that it has signed an agreement successfully with PAAM laboratories. The agreement has included a commitment by Eurofins for investing in laboratory, with new innovation, research & development, employee development and job security. • In March 2022, Mylab Discovery Solutions has announced that it is going to launch routine lab diagnostic testing kits and reagent business. This new launch will include kits and devices for biochemistry, immunology and haematology. The Mylab Company will help in addressing more than 90% of needs to small & medium size labs by entry in new business segments.
Companies Mentioned
- Abbott Laboratories
- Apollo Hospitals Enterprise Limited
- IDEXX Laboratories, Inc.
- F. Hoffmann-La Roche AG,
- Laboratory Corporation
- Siemens Healthineers
- Quest Diagnostics
- Thermo Fisher Scientific Inc
- Eurofins Scientific SE
- Exact Sciences Corp
- SYNLAB Group
- Sonic Healthcare Limited
- SGS S.A.
- Dr Lal PathLabs Limited
- Myriad Genetics, Inc
Table of Contents
- Table of Contents
- 1. Executive Summary
- 2. Market Dynamics
- 2.1. Market Drivers & Opportunities
- 2.2. Market Restraints & Challenges
- 2.3. Market Trends
- 2.4. Covid-19 Effect
- 2.5. Supply chain Analysis
- 2.6. Policy & Regulatory Framework
- 2.7. Industry Experts Views
- 3. Research Methodology
- 3.1. Secondary Research
- 3.2. Primary Data Collection
- 3.3. Market Formation & Validation
- 3.4. Report Writing, Quality Check & Delivery
- 4. Market Structure
- 4.1. Market Considerate
- 4.2. Assumptions
- 4.3. Limitations
- 4.4. Abbreviations
- 4.5. Sources
- 4.6. Definitions
- 5. Economic /Demographic Snapshot
- 6. Global Diagnostic Lab Market Outlook
- 6.1. Market Size By Value
- 6.2. Market Share By Region
- 6.3. Market Size and Forecast, By Geography
- 6.4. Market Size and Forecast, By Testing Services
- 6.5. Market Size and Forecast, By Lab Type
- 6.6. Market Size and Forecast, By Revenue Source
- 7. North America Diagnostic Lab Market Outlook
- 7.1. Market Size By Value
- 7.2. Market Share By Country
- 7.3. Market Size and Forecast, By Testing Services
- 7.4. Market Size and Forecast, By Lab Type
- 7.5. Market Size and Forecast, By Revenue Source
- 7.6. United States Diagnostic Lab Market Outlook
- 7.6.1. Market Size By Value
- 7.6.2. Market Size and Forecast By Testing Services
- 7.6.3. Market Size and Forecast By Lab Type
- 7.6.4. Market Size and Forecast By Revenue Source
- 7.7. Canada Diagnostic Lab Market Outlook
- 7.7.1. Market Size By Value
- 7.7.2. Market Size and Forecast By Testing Services
- 7.7.3. Market Size and Forecast By Lab Type
- 7.7.4. Market Size and Forecast By Revenue Source
- 7.8. Mexico Diagnostic Lab Market Outlook
- 7.8.1. Market Size By Value
- 7.8.2. Market Size and Forecast By Testing Services
- 7.8.3. Market Size and Forecast By Lab Type
- 7.8.4. Market Size and Forecast By Revenue Source
- 8. Europe Diagnostic Lab Market Outlook
- 8.1. Market Size By Value
- 8.2. Market Share By Country
- 8.3. Market Size and Forecast, By Testing Services
- 8.4. Market Size and Forecast, By Lab Type
- 8.5. Market Size and Forecast, By Revenue Source
- 8.6. Germany Diagnostic Lab Market Outlook
- 8.6.1. Market Size By Value
- 8.6.2. Market Size and Forecast By Testing Services
- 8.6.3. Market Size and Forecast By Lab Type
- 8.6.4. Market Size and Forecast By Revenue Source
- 8.7. United Kingdom Diagnostic Lab Market Outlook
- 8.7.1. Market Size By Value
- 8.7.2. Market Size and Forecast By Testing Services
- 8.7.3. Market Size and Forecast By Lab Type
- 8.7.4. Market Size and Forecast By Revenue Source
- 8.8. France Diagnostic Lab Market Outlook
- 8.8.1. Market Size By Value
- 8.8.2. Market Size and Forecast By Testing Services
- 8.8.3. Market Size and Forecast By Lab Type
- 8.8.4. Market Size and Forecast By Revenue Source
- 8.9. Italy Diagnostic Lab Market Outlook
- 8.9.1. Market Size By Value
- 8.9.2. Market Size and Forecast By Testing Services
- 8.9.3. Market Size and Forecast By Lab Type
- 8.9.4. Market Size and Forecast By Revenue Source
- 8.10. Spain Diagnostic Lab Market Outlook
- 8.10.1. Market Size By Value
- 8.10.2. Market Size and Forecast By Testing Services
- 8.10.3. Market Size and Forecast By Lab Type
- 8.10.4. Market Size and Forecast By Revenue Source
- 8.11. Russia Diagnostic Lab Market Outlook
- 8.11.1. Market Size By Value
- 8.11.2. Market Size and Forecast By Testing Services
- 8.11.3. Market Size and Forecast By Lab Type
- 8.11.4. Market Size and Forecast By Revenue Source
- 9. Asia-Pacific Diagnostic Lab Market Outlook
- 9.1. Market Size By Value
- 9.2. Market Share By Country
- 9.3. Market Size and Forecast, By Testing Services
- 9.4. Market Size and Forecast, By Lab Type
- 9.5. Market Size and Forecast, By Revenue Source
- 9.6. China Diagnostic Lab Market Outlook
- 9.6.1. Market Size By Value
- 9.6.2. Market Size and Forecast By Testing Services
- 9.6.3. Market Size and Forecast By Lab Type
- 9.6.4. Market Size and Forecast By Revenue Source
- 9.7. Japan Diagnostic Lab Market Outlook
- 9.7.1. Market Size By Value
- 9.7.2. Market Size and Forecast By Testing Services
- 9.7.3. Market Size and Forecast By Lab Type
- 9.7.4. Market Size and Forecast By Revenue Source
- 9.8. India Diagnostic Lab Market Outlook
- 9.8.1. Market Size By Value
- 9.8.2. Market Size and Forecast By Testing Services
- 9.8.3. Market Size and Forecast By Lab Type
- 9.8.4. Market Size and Forecast By Revenue Source
- 9.9. Australia Diagnostic Lab Market Outlook
- 9.9.1. Market Size By Value
- 9.9.2. Market Size and Forecast By Testing Services
- 9.9.3. Market Size and Forecast By Lab Type
- 9.9.4. Market Size and Forecast By Revenue Source
- 9.10. South Korea Diagnostic Lab Market Outlook
- 9.10.1. Market Size By Value
- 9.10.2. Market Size and Forecast By Testing Services
- 9.10.3. Market Size and Forecast By Lab Type
- 9.10.4. Market Size and Forecast By Revenue Source
- 10. South America Diagnostic Lab Market Outlook
- 10.1. Market Size By Value
- 10.2. Market Share By Country
- 10.3. Market Size and Forecast, By Testing Services
- 10.4. Market Size and Forecast, By Lab Type
- 10.5. Market Size and Forecast, By Revenue Source
- 10.6. Brazil Diagnostic Lab Market Outlook
- 10.6.1. Market Size By Value
- 10.6.2. Market Size and Forecast By Testing Services
- 10.6.3. Market Size and Forecast By Lab Type
- 10.6.4. Market Size and Forecast By Revenue Source
- 10.7. Argentina Diagnostic Lab Market Outlook
- 10.7.1. Market Size By Value
- 10.7.2. Market Size and Forecast By Testing Services
- 10.7.3. Market Size and Forecast By Lab Type
- 10.7.4. Market Size and Forecast By Revenue Source
- 10.8. Columbia Diagnostic Lab Market Outlook
- 10.8.1. Market Size By Value
- 10.8.2. Market Size and Forecast By Testing Services
- 10.8.3. Market Size and Forecast By Lab Type
- 10.8.4. Market Size and Forecast By Revenue Source
- 11. Middle East & Africa Diagnostic Lab Market Outlook
- 11.1. Market Size By Value
- 11.2. Market Share By Country
- 11.3. Market Size and Forecast, By Testing Services
- 11.4. Market Size and Forecast, By Lab Type
- 11.5. Market Size and Forecast, By Revenue Source
- 11.6. UAE Diagnostic Lab Market Outlook
- 11.6.1. Market Size By Value
- 11.6.2. Market Size and Forecast By Testing Services
- 11.6.3. Market Size and Forecast By Lab Type
- 11.6.4. Market Size and Forecast By Revenue Source
- 11.7. Saudi Arabia Diagnostic Lab Market Outlook
- 11.7.1. Market Size By Value
- 11.7.2. Market Size and Forecast By Testing Services
- 11.7.3. Market Size and Forecast By Lab Type
- 11.7.4. Market Size and Forecast By Revenue Source
- 11.8. South Africa Diagnostic Lab Market Outlook
- 11.8.1. Market Size By Value
- 11.8.2. Market Size and Forecast By Testing Services
- 11.8.3. Market Size and Forecast By Lab Type
- 11.8.4. Market Size and Forecast By Revenue Source
- 12. Competitive Landscape
- 12.1. Competitive Dashboard
- 12.2. Business Strategies Adopted by Key Players
- 12.3. Key Players Market Share Insights and Analysis, 2022
- 12.4. Key Players Market Positioning Matrix
- 12.5. Porter's Five Forces
- 12.6. Company Profile
- 12.6.1. Eurofins Scientific SE
- 12.6.1.1. Company Snapshot
- 12.6.1.2. Company Overview
- 12.6.1.3. Financial Highlights
- 12.6.1.4. Geographic Insights
- 12.6.1.5. Business Segment & Performance
- 12.6.1.6. Product Portfolio
- 12.6.1.7. Key Executives
- 12.6.1.8. Strategic Moves & Developments
- 12.6.2. Quest Diagnostics
- 12.6.3. F. Hoffmann-La Roche AG
- 12.6.4. Thermo Fisher Scientific Inc.
- 12.6.5. Exact Sciences Corp
- 12.6.6. Abbott Laboratories
- 12.6.7. Siemens Healthineers AG
- 12.6.8. SYNLAB Group
- 12.6.9. Sonic Healthcare Limited
- 12.6.10. SGS S.A.
- 12.6.11. Apollo Hospitals Enterprise Limited
- 12.6.12. Dr Lal PathLabs Limited
- 12.6.13. Laboratory Corporation of America Holdings
- 12.6.14. Myriad Genetics, Inc
- 12.6.15. IDEXX Laboratories, Inc
- 13. Strategic Recommendations
- 14. Annexure
- 14.1. FAQ`s
- 14.2. Notes
- 14.3. Related Reports
- 15. Disclaimer
Table 1: Global Diagnostic Lab Market Snapshot, By Segmentation (2023 & 2029) (in USD Billion)
Table 2: Influencing Factors for Diagnostic Lab Market, 2023
Table 3: Top 10 Counties Economic Snapshot 2022
Table 4: Economic Snapshot of Other Prominent Countries 2022
Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 6: Global Diagnostic Lab Market Size and Forecast, By Geography (2018 to 2029F) (In USD Billion)
Table 7: Global Diagnostic Lab Market Size and Forecast, By Testing Services (2018 to 2029F) (In USD Billion)
Table 8: Global Diagnostic Lab Market Size and Forecast, By Lab Type (2018 to 2029F) (In USD Billion)
Table 9: Global Diagnostic Lab Market Size and Forecast, By Revenue Source (2018 to 2029F) (In USD Billion)
Table 10: North America Diagnostic Lab Market Size and Forecast, By Testing Services (2018 to 2029F) (In USD Billion)
Table 11: North America Diagnostic Lab Market Size and Forecast, By Lab Type (2018 to 2029F) (In USD Billion)
Table 12: North America Diagnostic Lab Market Size and Forecast, By Revenue Source (2018 to 2029F) (In USD Billion)
Table 13: United States Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 14: United States Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 15: United States Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 16: Canada Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 17: Canada Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 18: Canada Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 19: Mexico Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 20: Mexico Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 21: Mexico Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 22: Europe Diagnostic Lab Market Size and Forecast, By Testing Services (2018 to 2029F) (In USD Billion)
Table 23: Europe Diagnostic Lab Market Size and Forecast, By Lab Type (2018 to 2029F) (In USD Billion)
Table 24: Europe Diagnostic Lab Market Size and Forecast, By Revenue Source (2018 to 2029F) (In USD Billion)
Table 25: Germany Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 26: Germany Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 27: Germany Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 28: United Kingdom Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 29: United Kingdom Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 30: United Kingdom Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 31: France Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 32: France Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 33: France Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 34: Italy Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 35: Italy Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 36: Italy Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 37: Spain Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 38: Spain Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 39: Spain Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 40: Russia Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 41: Russia Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 42: Russia Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 43: Asia-Pacific Diagnostic Lab Market Size and Forecast, By Testing Services (2018 to 2029F) (In USD Billion)
Table 44: Asia-Pacific Diagnostic Lab Market Size and Forecast, By Lab Type (2018 to 2029F) (In USD Billion)
Table 45: Asia-Pacific Diagnostic Lab Market Size and Forecast, By Revenue Source (2018 to 2029F) (In USD Billion)
Table 46: China Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 47: China Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 48: China Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 49: Japan Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 50: Japan Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 51: Japan Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 52: India Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 53: India Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 54: India Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 55: Australia Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 56: Australia Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 57: Australia Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 58: South Korea Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 59: South Korea Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 60: South Korea Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 61: South America Diagnostic Lab Market Size and Forecast, By Testing Services (2018 to 2029F) (In USD Billion)
Table 62: South America Diagnostic Lab Market Size and Forecast, By Lab Type (2018 to 2029F) (In USD Billion)
Table 63: South America Diagnostic Lab Market Size and Forecast, By Revenue Source (2018 to 2029F) (In USD Billion)
Table 64: Brazil Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 65: Brazil Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 66: Brazil Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 67: Argentina Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 68: Argentina Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 69: Argentina Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 70: Colombia Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 71: Colombia Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 72: Colombia Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 73: Middle East & Africa Diagnostic Lab Market Size and Forecast, By Testing Services (2018 to 2029F) (In USD Billion)
Table 74: Middle East & Africa Diagnostic Lab Market Size and Forecast, By Lab Type (2018 to 2029F) (In USD Billion)
Table 75: Middle East & Africa Diagnostic Lab Market Size and Forecast, By Revenue Source (2018 to 2029F) (In USD Billion)
Table 76: United Arab Emirates Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 77: United Arab Emirates Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 78: United Arab Emirates Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 79: Saudi Arabia Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 80: Saudi Arabia Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 81: Saudi Arabia Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Table 82: South Africa Diagnostic Lab Market Size and Forecast By Testing Services (2018 to 2029F) (In USD Billion)
Table 83: South Africa Diagnostic Lab Market Size and Forecast By Lab Type (2018 to 2029F) (In USD Billion)
Table 84: South Africa Diagnostic Lab Market Size and Forecast By Revenue Source (2018 to 2029F) (In USD Billion)
Figure 1: Global Diagnostic Lab Market Size (USD Billion) By Region, 2023 & 2029
Figure 2: Market attractiveness Index, By Region 2029
Figure 3: Market attractiveness Index, By Segment 2029
Figure 4: Global Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 5: Global Diagnostic Lab Market Share By Region (2023)
Figure 6: North America Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 7: North America Diagnostic Lab Market Share By Country (2023)
Figure 8: US Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 9: Canada Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 10: Mexico Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 11: Europe Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 12: Europe Diagnostic Lab Market Share By Country (2023)
Figure 13: Germany Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 14: UK Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 15: France Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 16: Italy Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 17: Spain Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 18: Russia Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 19: Asia-Pacific Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 20: Asia-Pacific Diagnostic Lab Market Share By Country (2023)
Figure 21: China Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 22: Japan Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 23: India Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 24: Australia Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 25: South Korea Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 26: South America Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 27: South America Diagnostic Lab Market Share By Country (2023)
Figure 28: Brazil Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 29: Argentina Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 30: Columbia Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 31: Middle East & Africa Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 32: Middle East & Africa Diagnostic Lab Market Share By Country (2023)
Figure 33: UAE Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 34: Saudi Arabia Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 35: South Africa Diagnostic Lab Market Size By Value (2018, 2023 & 2029F) (in USD Billion)
Figure 36: Competitive Dashboard of top 5 players, 2023
Figure 37: Market Share insights of key players, 2023
Figure 38: Porter's Five Forces of Global Diagnostic Lab Market
Diagnostic labs Market Market Research FAQs
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (22 December, 2024)
- Notify To Team (22 December, 2024)
- Report updation (23 December, 2024)
- Report Quality Check (23 December, 2024)
- Report Dispatch (24 December, 2024)
- Hard Copy
Recently Viewed Products
Global Diagnostics Labs Market Outlook, 2029
We are friendly and approachable, give us a call.